Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women

NCT05622838 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05622838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05622838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2022
Completion date
January 31, 2025
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alpha1 anti-trypsin, intrauterine growth restriction, pre-eclampsia